Fig. 9From: Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patientsTM expression on the endothelial cell surface within three days of RA treatment. Daily doses of RA are taken at t = 0 h, t = 24 h, and t = 48 h. (a) \( 45\frac{mg}{m^2} \) and (b) 110 \( \frac{mg}{m^2} \). The lines show the mean simulated results, while the shaded regions denote the 99% confidence interval of the mean simulated resultsBack to article page